While previous studies have shown an association between cancer occurrence and CHC1L deletion/under-expression, a reverse genetic approach is needed to show the contribution of loss of function to tumorigenesis in order to validate its hypothesized tumor suppressive function. The gene discussed is RCBTB2; the disease is neoplasm.